D-0330-2021 Class III Ongoing
FDA drug recall D-0330-2021 was initiated by Asclemed USA Inc. Dba Enovachem Pharmaceuticals on Mar 19, 2021 and is designated Class III. Reason for recall: Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 21, 2021
- Initiation Date
- Mar 19, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608
Reason for recall
Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
Distribution pattern
Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.
Code information
Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0330-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026